These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8028744)

  • 21. A population-based treat-to-target pharmacoeconomic analysis of HMG-CoA reductase inhibitors in hypercholesterolemia.
    Hilleman DE; Phillips JO; Mohiuddin SM; Ryschon KL; Pedersen CA
    Clin Ther; 1999 Mar; 21(3):536-62. PubMed ID: 10321422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of cholesterol-lowering treatment in Japanese elderly patients with coronary artery disease and normal cholesterol level using 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Chikamori T; Sugimoto K; Hamada T; Kitaoka H; Furuno T; Seo H; Doi Y
    J Cardiol; 2000 Feb; 35(2):95-101. PubMed ID: 10713930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long term treatment of moderate to severe hypercholesterolemia with low dose statin. Comparison of simvastatin and pravastatin].
    Spagnolli W; Ramponi C; Focher C; Dal Piaz A; Torboli P; Miori R; De Venuto G
    Recenti Prog Med; 1996 Nov; 87(11):538-42. PubMed ID: 9122535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of plasma cholesterol reduction by pravastatin on the functional properties of forearm arteries in hypercholesterolemic patients.
    Baldassarre D; Busnach G; Amato M; Pazzucconi F; Sirtori CR
    Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):108-17. PubMed ID: 10464783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marked improvement in cholestasis and hypercholesterolemia with simvastatin in a patient with primary biliary cirrhosis.
    Kamisako T; Adachi Y
    Am J Gastroenterol; 1995 Jul; 90(7):1187-8. PubMed ID: 7611234
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of treatment with Simvastatin in elderly patients with primary hypercholesterolemia.
    Terranova R; Luca S
    Riv Eur Sci Med Farmacol; 1993; 15(3-4):163-70. PubMed ID: 7761664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simvastatin reduces forearm vascular responsiveness to norepinephrine.
    Abbott D; Daher A; Manwaring P; Howes LG
    Atherosclerosis; 1997 Jun; 131(2):263-4. PubMed ID: 9199281
    [No Abstract]   [Full Text] [Related]  

  • 29. The conservative treatment of xanthoma of the Achilles tendon in patients affected with type IIA hypercholesterolemia.
    Valeo M; Dalla Vedova P; Di Giorgio L; Scarno AG; Giuliante A
    Chir Organi Mov; 1996; 81(3):303-10. PubMed ID: 9009414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoproteins and cardiovascular reactivity.
    Howes LG; Abbott D; Straznicky NE
    Br J Clin Pharmacol; 1997 Oct; 44(4):319-24. PubMed ID: 9354305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholesterol, statins, and mortality.
    Goldstein MR; Mascitelli L; Pezzetta F
    Lancet; 2008 Apr; 371(9619):1161; author reply 1162-3. PubMed ID: 18395569
    [No Abstract]   [Full Text] [Related]  

  • 32. Is a reduction of graft vessel disease by maximal treatment of hypercholesterolemia after heart transplantation possible?
    Wenke K; Meiser B; Thiery J; Arndtz N; von Scheidt W; Seidel D; Reichart B
    Transplant Proc; 1995 Jun; 27(3):1954-5. PubMed ID: 7792848
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cholesterol. On its significance in gerner practice].
    Schönwandt M
    Z Allgemeinmed; 1974 Nov; 50(31):1399-401. PubMed ID: 4464666
    [No Abstract]   [Full Text] [Related]  

  • 34. Cholesterol, statins, and mortality.
    Ong HT; Haniffah AG
    Lancet; 2008 Apr; 371(9619):1161; author reply 1162-3. PubMed ID: 18395570
    [No Abstract]   [Full Text] [Related]  

  • 35. Cholesterol, statins, and mortality.
    Law M; Wald N
    Lancet; 2008 Apr; 371(9619):1161-2; author reply 1162-3. PubMed ID: 18395571
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacologic advantages of individual cholesterol synthesis inhibitors? Prof. Dr. Dr. med. W. Schunack, Free University Berlin, elaborates on differential therapeutic considerations].
    Schunack W
    Fortschr Med; 1991 Jun; 109(19):71-2. PubMed ID: 1916563
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of manganese-induced hypercholesterolemia on learning in rats.
    Sentürk UK; Oner G
    Biol Trace Elem Res; 1996 Mar; 51(3):249-57. PubMed ID: 8727672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental hypocholesterolemic effect of cholesterol oxidase].
    Slobodskaia VV; Titov AV; Tereshin IM
    Vopr Med Khim; 1980; 26(6):735-8. PubMed ID: 6935870
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of hypercholesteremia with beta-pyridylcarbinol. I. Biochemistry and clinical results].
    Zöllner N; Gudenzi M
    Med Klin; 1966 Dec; 61(50):1996-2001. PubMed ID: 5994695
    [No Abstract]   [Full Text] [Related]  

  • 40. Cholesterol, statins, and mortality.
    Antoine-Jonville S; Hue O
    Lancet; 2008 Apr; 371(9619):1163. PubMed ID: 18395573
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.